Hc Advisors, LLC Black Diamond Therapeutics, Inc. Transaction History

Hc Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$12.19 - $28.17 $101,542 - $234,656	-8,330 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$22.23 - $34.75 $3,045 - $4,760	-137 Reduced 1.62%	8,330 $202,000
Q4 2020 Feb 08, 2021	BUY	$29.47 - $35.0 $52,810 - $62,720	1,792 Added 26.85%	8,467 $271,000
Q3 2020 Nov 04, 2020	BUY	$26.17 - $43.07 $174,684 - $287,492	6,675 New	6,675 $202,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $80.7M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hc Advisors, LLC with notifications on news.